Oravital Inc. Launches the Most Advanced Oral Infection Diagnosis and Treatment System into the US Dental Market
Toronto, CA – July 14, 2015 – Oravital
Inc., is now introducing its highly successful proprietary Oravital®
Oral Health System to the U.S. professional dental market. The company which was formed in 2008 and
currently has a network certified dental offices throughout Canada, plans to
replicate its success in the United States.
According to company president
and CEO Dr. Jim Hyland, “Undiagnosed and untreated oral infections are a North
American epidemic and include gum disease and halitosis. We also know that gum
disease is a contributing factor to many systemic conditions such as
cardiovascular disease, Alzheimer’s and diabetes. The time is right to share
the Canadian clinical success of the Oravital® System with our
American dental colleagues and their patients.”
The Oravital® System
is a five-step system based on identifying the cause of oral infection through
microbial analysis and tests for bleeding gums before scaling. After diagnosis,
treatment includes a customized antibiotic mouthwash used for a two-week
period, accompanied by proper home oral care using additional, specific
Oravital® products that are recommended based upon the patient’s
individual condition.
One early adopter in the US is
Dr. Robert McBride who practices in Long Beach, CA. Dr. McBride is
certified in using the Oravital® System for treating both
periodontal disease and halitosis. “In the past,we attempted to accurately
assess our patients' oral environment via phase microscopy and laboratory tests that many patients
rejected due to expense. The Oravital® System is a more cost
effective and patient-accepted option. The
system offers a comprehensive quantification of the oral microbial
environment along with user-friendly and effective preventive and
treatment protocols. This provides a solution to oral malodor while treating
periodontal disease as well.”
For more information on the
Oravital system and how your dental practice can become a certified Oravital
Clinic, visit www.Oravital.com or
call 1-800-909-6468.
Oravital Product Backgrounder
The
Oravital® System is very thorough and consists of the following 5
steps:
1.
Screening: Using a swab, the dentist or
hygienist takes bacterial samples from the patient’s tongue, throat and teeth.
These samples are sent to a laboratory for analysis to identify any harmful
bacteria that may be causing gum disease and breath odor.
2.
Treatment: If the report indicates there are harmful
microorganisms in the patient’s mouth that are causing gum and/or breath
problems, the dentist/hygienist will recommend an Oravital®
antibiotic and/or antimicrobial rinse that is specifically targeted to kill the
germs causing the infection. The patient uses the prescribed Oravital®
rinse for approximately two weeks until the harmful bacteria are under control
and a proper balance of healthy bacteria returns.
3.
Evaluation: Following initial treatment, the patient is
scheduled for another dental checkup to evaluate their gum health.
4.
Maintenance: Regular dental hygiene appointments and good
oral home care will ensure the patient maintains a healthy mouth. Along with
regular brushing and cleaning between their teeth, using an Oravital®
maintenance rinse on a daily basis will help patients prevent recurring gum and
breath problems.
5.
Revaluation: The company recommends Oravital®
microbial testing at least once a year to determine whether the bacteria in the
patient’s mouth are still in balance. If harmful bacteria levels are
increasing, infection could return. It's easier to address any problems before
this happens.
Oravital Inc. Company
Backgrounder
Oravital Inc. was established in the fall
of 2007 in Toronto, Canada. The company licenses proprietary technology called
the Oravital® System to certified dental clinics throughout North
America for the most advanced, effective and painless diagnosis and treatment
of oral infections available today.
Previously, oral infections
causing gum disease and bad breath had been difficult to diagnose and treat
successfully. With recent studies linking oral infections with systemic
conditions such as heart disease and diabetes, gum disease is now considered a
medical condition dental professionals should treat. Given that 75% of the population
continues to have signs of periodontal disease, diagnosis and predictable
treatment of this infection has become extremely important.
The
Oravital® System is highly effective in eliminating mild to moderate
gum disease as well as bad breath in just two weeks. The Oravital®
System is based on identifying the cause of oral infection through microbial
analysis and tests for bleeding gums. Treatment includes a customized
antibiotic rinse used for a two-week period, accompanied by unique gum cleaning
techniques for the patient to follow.
The
science of Oravital® evolved from 15 years of ground-breaking
research and successful clinical treatment by Anne Bosy, RDH, MEd, MSc,
co-founder of Toronto's Fresh Breath Clinic. Dr. Walter Loesche, who was a
respected authority on periodontal disease treatment at the University of The
Michigan,
validated the effectiveness of the antibiotic therapy developed by Anne Bosy.
The following are members of Oravital's executive management team:
- Dr. James Hyland, BSc, DDS / President & CEO
- Ms. Anne Bosy RRDH, MEd, MSc / Founder, VP of Clinical Affairs and Chief Science Officer
- Robert Isaacson, CPA, CA, MBA / Founder, Vice Chairman and Chief Financial Officer
- Michael Hart / Chairman of the Board
Oravital Inc. also provides a
comprehensive, dynamic and scientifically-grounded training program to its
clinics. Oravital® certified dental professionals are authorized
experts in providing Oravital® diagnostic analysis, individualized
treatment, and dedicated long-term support. For more information, visit www.Oravital.com or
call 1-800-909-6468.
# # #
Comments